Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Inovio Pharmaceuticals, Inc. (INO) had Return on Equity of -352.53% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.07M |
|
$-84.95M |
|
-- |
|
$0.07M |
|
$86.89M |
|
$-86.82M |
|
$1.88M |
|
$-84.95M |
|
$-84.95M |
|
$-84.95M |
|
$-84.95M |
|
$-84.95M |
|
$-84.95M |
|
$-86.82M |
|
$-83.84M |
|
46.89M |
|
46.89M |
|
$-1.81 |
|
$-1.81 |
|
| Balance Sheet Financials | |
$61.12M |
|
$2.53M |
|
$13.19M |
|
$74.31M |
|
$43.67M |
|
-- |
|
$6.55M |
|
$50.21M |
|
$24.10M |
|
$24.10M |
|
$24.10M |
|
69.00M |
|
| Cash Flow Statement Financials | |
$-88.63M |
|
$14.04M |
|
$53.05M |
|
$65.81M |
|
$44.27M |
|
$-21.54M |
|
$3.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-132871.30% |
|
-132871.30% |
|
-128300.90% |
|
-130000.00% |
|
-130000.00% |
|
$-88.92M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-352.53% |
-352.53% |
|
-114.31% |
|
-352.53% |
|
$0.35 |
|
$-1.90 |
|
$-1.89 |
|